PMID: 16633205Apr 25, 2006Paper

Electroconvulsive therapy in first-episode schizophrenia

The Journal of ECT
Alp Uçok, Sibel Cakir

Abstract

Knowledge about the efficacy of electroconvulsive therapy (ECT) on schizophrenia comes from chronic patients and little known on young, first-episode patients. The aim of this study is to evaluate short-term and long-term efficacy of ECT in patients with first-episode schizophrenia. In the first phase of the study, 90 hospitalized, first-episode patients with schizophrenia were enrolled; psychopathology was evaluated with Brief Psychiatric Research Scale (BPRS), Scale for the Assessment of Positive Symptoms (SAPS), and Scale for the Assessment of Negative Symptoms (SANS) on admission and discharge. Antipsychotics were first-line treatment for most of the patients, but medication for nonrespondent catatonic patients and patients who had violent behaviors were treated with ECT. The patients who met the remission criteria were intended to a 1-year follow-up after discharge. BPRS, SAPS, and SANS were monthly recorded during the follow-up. Differences in clinical characteristics, relapse, and rehospitalization rates were analyzed in patients with or without ECT treatment. Thirteen patients were treated with ECT. They were low educated and were more likely nonparanoid subtypes (catatonic, disorganized). The ECT group had higher BPRS ...Continue Reading

References

Jan 1, 1996·Schizophrenia Bulletin·M Fink, H A Sackeim
May 1, 1997·The American Journal of Psychiatry·J M Rey, G Walter
Oct 21, 2000·The British Journal of Psychiatry : the Journal of Mental Science·T R BarnesE M Joyce
Nov 9, 2001·Journal of the American Academy of Child and Adolescent Psychiatry·Y BlochG Ratzoni
Dec 13, 2001·Psychiatry Research·W Chanpattana, M L Chakrabhand
Apr 18, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jeffrey A LiebermanRobert M Hamer
Feb 6, 2004·Journal of Psychiatric Research·Alp UçokNurten Turan
Nov 13, 2004·European Archives of Psychiatry and Clinical Neuroscience·K H KhoD H Linszen
Jan 6, 2005·Schizophrenia Bulletin·Alexander L MillerSteven Shon
May 21, 2005·The Journal of ECT·Raphael J Braga, Georgios Petrides

❮ Previous
Next ❯

Citations

Dec 7, 2010·European Archives of Psychiatry and Clinical Neuroscience·Diana KristensenMartin Balslev Jørgensen
Jun 29, 2010·Journal of Child and Adolescent Psychopharmacology·Inmaculada BaezaJosefina Castro-Fornieles
Jan 1, 2011·Revista de psiquiatrí́a y salud mental·Francisco Javier Sanz-FuentenebroErnesto Verdura Vizcaíno
Nov 30, 2011·Criminal Behaviour and Mental Health : CBMH·Diana KristensenMartin Balslev Jørgensen
Jul 17, 2013·Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists·Nien-Mu ChiuWen-Kuei Lee
Apr 8, 2016·International Journal of Psychiatry in Clinical Practice·Stefano PorcelliAlessandro Serretti
Sep 4, 2014·European Child & Adolescent Psychiatry·Itziar FlamariqueJosefina Castro-Fornieles
Aug 9, 2018·Psychiatry Investigation·Jung Hyun KimIn Won Chung
Dec 7, 2018·Acta Neuropsychiatrica·Sandeep GroverRaman Koirala

❮ Previous
Next ❯

Related Concepts

Related Feeds

Catatonic Schizophrenia

Catatonia is a psychomotor symptom in which patients present with stupor, although catatonic excitement may also present at the other end of the spectrum. Catatonia has been historically associated with schizophrenia although it is also associated with other neuropsychiatric disorders. Find the latest research on catatonic schizophrenia here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here